The Crown Place VCT
Fund Overview
Crown Place VCT invests in a balanced portfolio of early-stage growth businesses across sectors like technology, healthcare, and FinTech. As of June 2022, the fund's net asset value stands at £85.8 million, with a NAV per share of 33.70p. The VCT has consistently aimed to provide shareholders with capital growth and regular tax-free dividends, maintaining a dividend target of approximately 5% of NAV annually.
The minimum investment is £5,000, targeting a strong annual dividend yield and long-term growth.
Investment Strategy
Crown Place VCT employs a multi-sector approach, emphasizing investments in high-growth sectors. Key highlights include:
- Portfolio Composition: Investments in both unquoted and AIM-listed companies.
- Sector Focus: Technology, healthcare, software, and renewable energy.
- Active Management: Collaborative partnerships with management teams to drive value.
- Long-term Objectives: Deliver consistent returns and maintain dividend payouts.
Recent investments include companies like PeakData, Ophelos, and Speechmatics, highlighting its commitment to innovation.
Performance Metrics
| Year | NAV Total Return (%) | Dividends Paid (p/share) |
|---|---|---|
| 2022 | 6.1 | 3.21 |
| 2021 | 15.9 | 3.61 |
| 2020 | -0.4 | 2.5 |
Cumulative Dividends: Since inception, shareholders have received over 66.55p per share in dividends.
Tax Benefits
Investors benefit from:
- 30% income tax relief: Available on investments up to £200,000 annually.
- Tax-free dividends: Enjoy regular income payments without tax liabilities.
- Capital gains tax exemption: No CGT on share disposals.
Tax treatment depends on individual circumstances and may change.
Fund Documents
Contact Information
- Phone: 020 7601 1850
- Email: [email protected]
- Website: Crown Place VCT
Why Consider Access EIS Instead?
Both Crown Place VCT and Access EIS offer tax-efficient investment opportunities, but they cater to different investor needs:
| Feature | Crown Place VCT | Access EIS |
|---|---|---|
| Investment Focus | Unquoted and AIM-listed companies | Early-stage, high-growth UK startups |
| Minimum Investment | £5,000 | £5,000 |
| Tax Benefits |
- 30% Income Tax Relief - Tax-Free Dividends - Capital Gains Tax Exemption |
- 30% Income Tax Relief - Capital Gains Tax Deferral |
| Liquidity | Limited liquidity through buyback schemes | Illiquid, with returns realized after ~5–7 years |
| Dividends | Regular, tax-free dividends | No dividends; all profits reinvested |
| Risk Level | Moderate to High | Very High |